Company Profile
Updated: 17-SEP-09Bioheart Inc.
Public Company, Headquarters Location
13794 NW 4th St., Ste. 212, Sunrise, FL 33325-6217, United States
(954)835-1500, (954)845-9976 fax, http://www.bioheartinc.com
Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Devices for treating heart disease. Services: Bio research.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
C-Level: Pre-Week Review.
Investrend; 11/16/2009; 1545 words; ...organic-alliance/). Jones Named To Bioheart Board: November 12, 2009 (FinancialWire) -- Bioheart, Inc. (OTCBB: BHRT) has elected Lee Jones...will serve as an independent director on Bioheart's board, has been the chief administrative...
Jones Named To Bioheart Board.
Investrend; 11/12/2009; 618 words; ...2009/11/12/jones-named-to-bioheart-board/) November 12, 2009 (FinancialWire) -- Bioheart, Inc. (OTCBB: BHRT) has elected Lee Jones...serve as an independent director on Bioheart's board, has been the chief administrative...
Bioheart Elects Lee Jones to Its Board of Directors.
PR Newswire; 11/11/2009; 1122 words; ...PRNewswire-FirstCall/ -- Bioheart, Inc. (OTC Bulletin Board: BHRT...Directors. On November 5, 2009, Bioheart, Inc. appointed Lee A. Jones to serve...s membership to eight. About Bioheart, Inc. Bioheart, Inc. is committed...
Stock Watch: APRU, BHRT, BSFG.
M2 Presswire; 11/11/2009; 1260 words; ...Inc. (PINKSHEETS: APRU); Bioheart, Inc. (OTC Bulletin Board: BHRT...Bioheart, Inc. closed at $1.00 Tuesday...Jones to Its Board of Directors Bioheart, Inc. (OTC Bulletin Board: BHRT...
Recovery of damaged heart possible through stem cells therapy.
Albawaba.com; 11/5/2009; 823 words; Bioheart has announced a medical breakthrough...to Dr Karl Groth, chairman and CEO, Bioheart Inc., a US-based company that is an investment...procedure with minimal intervention. Bioheart has developed a fully-automated, point...
Recent News Articles
- Bioheart Inc. Announces Positive Results in the MARVEL Phase II/III Clinical Trial.
Business Wire - September 16, 2009 - Bioheart Inc. is in the StockGuru Spotlight for September 11, 2009.
M2 Presswire - September 11, 2009 - Bioheart Inc. to Participate in the 2009 World Stem Cell Summit on September 23rd.
PR Newswire - September 10, 2009 - Bioheart, Inc. Announces Receipt of $2.8 Million in Proceeds From Pipe Financing.
Investment Weekly News - July 25, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
